Medicine & Life Sciences
1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione
30%
Antigens
6%
Ataxia Telangiectasia
18%
Bleomycin
6%
Breast Neoplasms
7%
Carcinogenesis
11%
Catalytic Domain
20%
Cell Cycle
24%
Cell Cycle Checkpoints
8%
Cell Line
6%
Chromosome Aberrations
9%
Cyclin-Dependent Kinases
7%
DNA
56%
DNA Damage
49%
DNA Mismatch Repair
6%
DNA Repair
46%
DNA-Activated Protein Kinase
39%
Double-Stranded DNA Breaks
100%
exodeoxyribonuclease I
19%
Exodeoxyribonucleases
9%
Fluorescence Spectrometry
7%
Genome
9%
Genomic Instability
39%
Heavy Ion Radiotherapy
8%
Holoenzymes
9%
Homologous Recombination
34%
Ionizing Radiation
18%
Kinetics
9%
Lasers
6%
Long Noncoding RNA
12%
Neoplasms
14%
O-(5-O-(4-coumaroyl)-alpha-arabinofuranosyl)-(1-3)-O-beta-xylopyranosyl-(1-4)-xylopyranose
10%
Oxidative Stress
8%
Phosphatidylinositol 3-Kinases
7%
Phosphorylation
25%
Phosphotransferases
10%
Proteasome Endopeptidase Complex
6%
Protein Kinases
9%
Protein Phosphatase 2
22%
Proteins
21%
Radiotherapy
7%
Recombinational DNA Repair
13%
RecQ Helicases
8%
Retinoblastoma Protein
7%
S Phase
16%
Serine
9%
Squamous Cell Carcinoma of Head and Neck
6%
Testicular Neoplasms
10%
Threonine
7%
Ubiquitination
6%